サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1634198

脳波測定装置の世界市場 - 2025年～2033年

Global Electroencephalography Devices Market - 2025 - 2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
脳波測定装置の世界市場 - 2025年～2033年
出版日: 2025年01月13日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の脳波測定装置市場は、2023年に14億8,000万米ドルに達し、2033年には30億8,000万米ドルに達すると予測され、予測期間2025年～2033年のCAGRは7.4％で成長します。

脳波（EEG）は、頭皮に取り付けた小型センサーで脳の活動を記録する痛みのない検査です。これらの信号は医師（通常は臨床神経生理学者）によって分析されます。脳波検査は、発作を繰り返すてんかんなど、さまざまな脳の状態の診断やモニタリングに役立ちます。脳波検査の主な用途は、てんかんの検出と調査であり、医師がてんかんのタイプ、誘発因子、患者にとって最善の治療法を特定するのに役立ちます。この検査は通常、高度な訓練を受けた専門医が通院中に実施します。

市場力学：

促進要因と抑制要因

技術的進歩の増加

技術の進歩は、脳波データの取り込み、分析、活用に革命を起こすことで、脳波（EEG）装置の世界市場における重要な促進要因の一つとなっています。ワイヤレスおよびウェアラブルEEGデバイスは、携帯性とユーザーの利便性を高め、臨床および非臨床環境でのリアルタイムモニタリングを可能にします。高密度EEGシステムと改良されたセンサー技術により、脳活動マッピングの精度が向上し、より優れた神経学的診断が可能になります。AIと機械学習アルゴリズムの統合により、データ解釈が一変し、複雑な神経学的状態に対してより迅速で正確な分析が可能になります。クラウドベースのデータストレージとIoT対応機器は、EEG技術の応用範囲を遠隔医療、ゲーム、認知研究にまで広げます。

例えば2024年4月、Soterix Medical社は、モバイル環境および自然環境での調査用途向けに設計された高精細経頭蓋電気刺激（HD-tES）とEEGを組み合わせたMxN-GO EEGを発売しました。軽量でワイヤフリーのこのシステムは、33の刺激チャンネルと32の記録チャンネルを備え、比類のない精度と用途に応じたターゲティングを提供します。mBrainTrainとの共同開発によるこのシステムは、迅速なセットアップと使いやすさを目指して設計されており、モバイルハイブリッド刺激／EEG研究のための究極のソリューションを提供します。

熟練した専門家の不足

世界の脳波（EEG）装置市場は、熟練した専門家の不足による課題に直面しており、先端技術の完全な活用が制限されています。正確な脳波記録と分析には、電極の配置、信号の取得、複雑な脳波データの解釈に関する専門知識が必要であるが、これはヘルスケア環境、特に新興市場では利用できないことが多いです。この不足は、てんかんや睡眠障害のような神経疾患の診断精度を妨げ、EEGデータに依存する研究イニシアチブに影響を与えます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 技術進歩の高まり
    • 抑制要因
      • 熟練した専門家の不足
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 製品タイプ別

  • ポータブルEEGデバイス
  • スタンドアロンEEGデバイス
  • ウェアラブルEEGデバイス
  • ワイヤレス EEGデバイス

第7章 用途別

  • 病気の診断
  • 監視
  • 調査

第8章 技術別

  • デジタル脳波
  • アナログ脳波

第9章 エンドユーザー別

  • 病院
  • 診断センター
  • 外来手術センター
  • 調査機関
  • 在宅ヘルスケア

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第12章 企業プロファイル

  • Natus Medical Incorporated
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • Compumedics Limited
  • Nihon Kohden Corporation
  • Medtronic plc
  • Neurosoft
  • Micromed Group
  • Cadwell Industries, Inc.
  • Electrical Geodesics, Inc（Philips Healthcare）
  • Brain Products GmbH
  • Advanced Brain Monitoring, Inc

第12章 付録

目次
Product Code: MD1422

The global electroencephalography devices market reached US$ 1.48 billion in 2023 and is expected to reach US$ 3.08 billion by 2033, growing at a CAGR of 7.4% during the forecast period 2025-2033.

An electroencephalogram (EEG) is a painless test that records brain activity using small sensors attached to the scalp. These signals are analyzed by a doctor, usually a clinical neurophysiologist. EEGs can help diagnose and monitor various brain conditions, such as epilepsy, which causes repeated seizures. The main use of EEGs is to detect and investigate epilepsy, helping doctors identify the type of epilepsy, triggers, and the best treatment for the patient. The procedure is usually carried out by a highly trained specialist during a hospital visit.

Market Dynamics: Drivers & Restraints

Rise in the Technological Advancements

Technological advancements are one of the significant driving factors in the Global Electroencephalography (EEG) Devices Market by revolutionizing brainwave data capture, analysis, and utilization. Wireless and wearable EEG devices enhance portability and user convenience, enabling real-time monitoring in clinical and non-clinical settings. High-density EEG systems and improved sensor technology improve brain activity mapping accuracy, enabling better neurological diagnosis. The integration of AI and machine learning algorithms transforms data interpretation, enabling faster, more precise analysis for complex neurological conditions. Cloud-based data storage and IoT-enabled devices broaden EEG technology's application across telemedicine, gaming, and cognitive research.

For instance, in April 2024, Soterix Medical has launched the MxN-GO EEG, a combined High Definition transcranial Electrical Stimulation (HD-tES) and EEG system designed for research applications in mobile and natural environments. The lightweight, wire-free system offers 33 stimulation channels and 32 recording channels, providing unparalleled precision and application-specific targeting. The system, developed in collaboration with mBrainTrain, is designed for rapid set-up and ease of use, offering the ultimate solution for mobile hybrid stimulation/EEG studies.

Lack of Skilled Professionals

The Global Electroencephalography (EEG) Devices Market faces challenges due to a shortage of skilled professionals, limiting the full utilization of advanced technologies. Accurate EEG recording and analysis require expertise in electrode placement, signal acquisition, and interpreting complex brainwave data, which is often unavailable in healthcare settings, especially in emerging markets. This shortage hampers diagnostic accuracy for neurological conditions like epilepsy and sleep disorders and affects research initiatives relying on EEG data.

For more details on this report - Request for Sample

Segment Analysis

The global electroencephalography devices market is segmented based on product type, application, technology, end user and region.

Product Type:

Portable EEG Devices segment is expected to dominate the Electroencephalography Devices market share

The portable EEG devices segment holds a major portion of the electroencephalography devices market share and is expected to continue to hold a significant portion of the electroencephalography devices market share during the forecast period.

Portable EEG devices are revolutionizing the Global Electroencephalography (EEG) Devices Market by providing accessibility and convenience in neurological diagnostics and monitoring. These devices are designed for mobility, allowing patients to undergo testing outside traditional clinical settings, particularly for conditions like epilepsy, sleep disorders, and brain injuries. Equipped with advanced wireless technologies, they enable real-time data transmission and integration with digital platforms for analysis and storage. Their compact design and user-friendly interfaces make them suitable for telemedicine applications, expanding their reach to underserved or remote areas.

For instance, in April 2024, NeuroVigil has launched its iBrain personal brain monitor in the U.S., a noninvasive device that records brain electrical activity in individuals with neurological conditions. The device, based on electroencephalogram (EEG) technology, can be used at home and during sleep for efficient and user-friendly EEG data collection. In the second phase, a smaller version will be used to detect signs of Parkinson's disease.

Application:-

Disease Diagnosis segment is the fastest-growing segment in Electroencephalography Devices market share

The disease diagnosis segment is the fastest-growing segment in the electroencephalography devices market share and is expected to hold the market share over the forecast period.

The Global Electroencephalography (EEG) Devices Market is driven by the need for early diagnosis and monitoring of various neurological conditions. EEG devices are used for detecting epilepsy, Alzheimer's, Parkinson's, stroke, and brain tumors. They also aid in diagnosing sleep disorders like insomnia and obstructive sleep apnea by monitoring brain activity during sleep cycles. The increasing prevalence of these disorders and the focus on early detection and personalized treatment have driven the demand for advanced EEG systems, including portable and wearable devices. This underscores the crucial role of EEG in improving neurological healthcare outcomes globally.

For instance, in December 2024, LVIS Corporation has launched NeuroMatch Access, a cloud-based SaaS platform designed to streamline EEG diagnostics review and improve physician collaboration. The platform, now available in the US, enables neurologists to quickly review and interpret EEG data, enabling real-time collaboration for more accurate and timely diagnoses. NeuroMatch, a cutting-edge technology that uses artificial intelligence to remove unwanted artifacts, enables clinicians to visualize and understand brain circuit communication pathways, facilitating targeted interventions and restorative strategies to enhance neurological health.

Geographical Analysis

North America is expected to hold a significant position in the Electroencephalography Devices market share

North America holds a substantial position in the electroencephalography devices market and is expected to hold most of the market share due to advanced healthcare infrastructure and increasing prevalence of neurological disorders like epilepsy, Alzheimer's, and Parkinson's. Demand for EEG devices is driven by high awareness of early diagnosis and treatment, company's partnerships, government and private funding for neuroscience research, widespread adoption of advanced devices like portable and wearable EEG systems, and ongoing innovation in AI and machine learning integration.

For instance, in January 2024, Gate Neurosciences has partnered with Beacon Biosignals to advance the use of electroencephalogram (EEG) biomarkers in neuropsychiatry and cognition. The collaboration will use Beacon Biosignals' Dreem 3S headband device and neurobiomarker platform to conduct exploratory EEG and sleep analyses in depressed patients enrolled in Gate's Phase 2 trial of zelquistinel, a rapid-acting, once-weekly oral NMDA receptor positive modulator for treating major depressive disorder.

Europe is growing at the fastest pace in the Electroencephalography Devices market

Europe holds the fastest pace in the electroencephalography devices market and is expected to hold most of the market share due to a increased healthcare investments and focus on mental health and neurological research. The increasing incidence of neurodegenerative diseases and sleep disorders in the aging population necessitates advanced diagnostic tools like EEG. Government initiatives and research grants are also driving this growth. The adoption of digital health solutions and home-based and telehealth monitoring further supports the EEG market expansion.

For instance, in December 2024, Neuroelectrics and Neuronostics have partnered to offer an integrated EEG solution for pharmaceutical, contract research organisations, and academic partners. The partnership combines Neuroelectrics' advanced EEG hardware with Neuronostics' proprietary analytics to streamline clinical trials and unlock new possibilities in neurological research. The platform enhances cohort identification, streamlines protocol design, and delivers precise EEG analysis, ensuring trials are efficient and impactful. This partnership addresses the critical need for high-quality, actionable data in clinical trials.

Competitive Landscape

The major global players in the electroencephalography devices market include Natus Medical Incorporated, Compumedics Limited, Nihon Kohden Corporation, Medtronic plc, Neurosoft, Micromed Group, Cadwell Industries, Inc, Electrical Geodesics, Inc (Philips Healthcare) Brain Products GmbH, Advanced Brain Monitoring, Inc and among others.

Key Developments

  • In May 2024, ChristianaCare has introduced an innovative EEG brain monitoring program, a first of its kind, which can be performed at the bedside to measure brain electrical activity, providing vital signs for brain function and enabling quicker diagnosis of seizures.
  • In January 2024, Aditxt, a health innovation company, has acquired a portfolio of EEG brain monitoring technologies and devices, formerly owned by Brain Scientific. The acquisition will help shape the neurology monitoring market and shape its dynamic landscape for neurological care.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global electroencephalography devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by Technology
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Skilled Professionals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Portable EEG Devices*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Standalone EEG Devices
  • 6.4. Wearable EEG Devices
  • 6.5. Wireless EEG Devices

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Disease Diagnosis*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Monitoring
  • 7.4. Research

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Digital EEG*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Analog EEG

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostic Centers
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Research Institutes
  • 9.6. Home Healthcare

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Natus Medical Incorporated*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Compumedics Limited
  • 12.3. Nihon Kohden Corporation
  • 12.4. Medtronic plc
  • 12.5. Neurosoft
  • 12.6. Micromed Group
  • 12.7. Cadwell Industries, Inc.
  • 12.8. Electrical Geodesics, Inc (Philips Healthcare)
  • 12.9. Brain Products GmbH
  • 12.10. Advanced Brain Monitoring, Inc

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us